Kemphys Ltd.
Records under this name other than the patents Kemphys Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,861,640 | Medicament for treatment of Alzheimer's disease Lapsed on the fee record Ended Jan 9, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jan 9, 2022 | From the USPTO record |
| US 8,431,613 | Memory fixation accelerator Lapsed on the fee record Ended Apr 30, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 30, 2021 | From the USPTO record |
| US 8,198,329 | Memory consolidation promoting agent and method of use Lapsed on the fee record Ended Jun 12, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2020 | From the USPTO record |
| US 9,353,134 | Silicon-containing carboxylic acid derivative Lapsed on the fee record Ended May 31, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2020 | From the USPTO record |
| US 8,030,360 | Anti-wrinkle agent Lapsed on the fee record Ended Oct 4, 2019 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2019 | From the USPTO record |
| US 8,895,769 | Silicon-containing carboxylic acid derivative Lapsed on the fee record Ended Nov 25, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 25, 2018 | From the USPTO record |
| US 6,838,574 | Dicarba-closo-dodecarborane derivatives Formerly held Lapsed on the fee record Ended Jan 4, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jan 4, 2017 | From the USPTO record |
| US 8,168,677 | Method for treatment of inflammatory bowel disease Lapsed on the fee record Ended May 1, 2016 · From the USPTO record | Lapsed on the fee record | Ended May 1, 2016 | From the USPTO record |
| US 8,071,647 | Method for treatment of adhesion of the intestines Lapsed on the fee record Ended Dec 6, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 6, 2015 | From the USPTO record |
| US 7,968,600 | Medicament for preventive and therapeutic treatment of physical dysfunction caused by nerve damage Formerly held Lapsed on the fee record Ended Jun 28, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jun 28, 2015 | From the USPTO record |